It depends on whether providers are willing to sign up for lower costs and better outcomes.
News & Analysis: Clover Health Investments
A short-seller asks questions about the company's business.
The company's guidance for 2021 was below expectations.
The Fools discuss one of today's most controversial health companies.
It's too early to know who's right.
Here's one hybrid health-tech SPAC that's a favorite among Reddit investors.
Convenience is key for these promising companies.
Most important: Don't jump the gun on any conclusions.
After decades of effort, electronic health records could finally get an upgrade that allows them to work as intended.
At $800 billion, Tesla's disruption appears to be largely priced in. But these brand-new SPACs have single-digit billion market caps and massive potential as well.